Viewing nowIbersartan 300 mg (Irbesartan)
Irbesartan 300mg
Tablet · Prescription medication
ShinPoong Pharmaceutical Co., Ltd.

MFDS item code 201102329 · Approved 2011.04.18 · Insurance code 648506530
Essential hypertension; treatment of nephropathy in patients with type 2 diabetes accompanied by hypertension
This medication is used to control blood pressure in patients with essential hypertension. It also helps prevent and treat kidney disease in patients with hypertension accompanying type 2 diabetes. Therefore, it is effective in improving cardiovascular and renal complications associated with hypertension.
This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer 150 mg of irbesartan orally once daily. If the effect is inadequate, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in certain cases (e.g., at the start of treatment, in patients receiving hemodialysis, or in elderly patients aged 75 years or older). If blood pressure control is inadequate with monotherapy, another antihypertensive agent may be administered concomitantly. The effect is increased particularly when used concomitantly with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to start oral administration of this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be administered concomitantly to achieve the target blood pressure. ○ Elderly patients Dosage adjustment is generally not necessary, but an initial dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dosage adjustment is generally not necessary, but an initial dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Although no specific dosage adjustment is generally necessary in patients with mild to moderate hepatic impairment, it is recommended not to exceed 150 mg per day. There is no clinical experience in patients with severe hepatic impairment.
This medication can cause serious harm to the fetus if used during pregnancy, especially during the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug or its components, those with severe liver dysfunction, pregnant or breastfeeding women, and individuals with certain hereditary lactose intolerance should not take this medication. Elderly patients, those with hyperkalemia, patients with weakened liver function, those with heart valve or muscle problems, and patients with poor kidney function should take this medication cautiously and should have their blood pressure and kidney function monitored frequently as directed by a physician. During the use of this medication, side effects such as dizziness, fatigue, headache, cough, and dyspepsia may occur, but they are generally mild and temporary. However, serious side effects such as angioedema with swelling of the face, lips, or tongue, severe hypotension, kidney failure, liver dysfunction, hypoglycemia, and myalgia may occur, so any unusual symptoms should be reported to healthcare professionals immediately. This medication may interact with other antihypertensive drugs, diuretics, potassium supplements, lithium, non-steroidal anti-inflammatory drugs, etc., so patients should inform their doctor or pharmacist if they are taking other medications. Pregnant or breastfeeding women are advised not to take this medication, and nursing should be stopped if this medication is taken while breastfeeding. Safety in children has not been established, so it is not to be administered to children. In case of an overdose, hypotension or cardiac arrhythmia may occur, so care should be taken not to exceed the dosage, and if an overdose is suspected, immediate medical attention is required. This medication should be kept out of reach of children and should not be transferred to other containers. Caution is required when driving or operating machinery as dizziness or fatigue may occur.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is also advisable to store it in a dry place at or below 30 degrees Celsius.
White or almost white, double convex oval film-coated tablet
30 tablets/box [(10 tablets/PTP × 3)], 100 tablets/bottle, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowIrbesartan 300mg
Tablet · Prescription medication
ShinPoong Pharmaceutical Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
Handok Co., Ltd.

Irbesartan 300mg
Tablet · Prescription medication
Handok Co., Ltd.
Irbesartan 150mg
Tablet · Prescription medication
Hanwha Pharmaceutical Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.
Irbesartan 150mg
Prescription medication
Bionex Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
KMS Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.